Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M N Saleh

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Clinical Nuclear Medicine|February 1, 1991
In-111 labeled monoclonal anti-carcinoembryonic antigen antibody (ZCE025) in the immunoscintigraphic imaging of metastatic antigen-producing adenocarcinomasM N Saleh, R H Wheeler, J Y Lee, et al.
Seminars in Oncology|February 28, 2001
A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopeniaM N Saleh, J Gutheil, M Moore, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 1, 1997
Correlation of toxicity with treatment parameters for 131I-CC49 radioimmunotherapy in three phase II clinical trialsT Liu, R F Meredith, M N Saleh, et al.
Journal of Biological Response Modifiers|April 1, 1990
Initial evaluation of a human immunoglobulin M monoclonal antibody (HA-1A) in humansM B Khazaeli, R Wheeler, K Rogers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1988
Clinical use of a standard kit-preparation of radiolabeled monoclonal antibody 96.5 in the diagnostic imaging of metastatic melanomaM N Saleh, D M Miller, L Peterson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2009
A randomized, phase II trial of two dose schedules of carboplatin/paclitaxel/cetuximab in stage IIIB/IV non-small-cell lung cancer (NSCLC)M A Socinski, M N Saleh, D F Trent, et al.
Cancer Research|August 25, 1991
Evidence for the elevation of serum carcinoembryonic antigen and tumor-associated glycoprotein-72 levels in patients administered interferonsJ W Greiner, F Guadagni, D Goldstein, et al.
Cancer Research|October 1, 1995
Phase II trial of murine monoclonal antibody D612 combined with recombinant human monocyte colony-stimulating factor (rhM-CSF) in patients with metastatic gastrointestinal cancerM N Saleh, M B Khazaeli, R H Wheeler, et al.
Cancer Research|October 1, 1993
A phase I clinical trial of murine monoclonal antibody D612 in patients with metastatic gastrointestinal cancerM N Saleh, M B Khazaeli, W E Grizzle, et al.
Cancer Research|August 15, 1992
Phase I trial of the murine monoclonal anti-GD2 antibody 14G2a in metastatic melanomaM N Saleh, M B Khazaeli, R H Wheeler, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Clinical Nuclear Medicine|February 1, 1991
In-111 labeled monoclonal anti-carcinoembryonic antigen antibody (ZCE025) in the immunoscintigraphic imaging of metastatic antigen-producing adenocarcinomasM N Saleh, R H Wheeler, J Y Lee, et al.
Seminars in Oncology|February 28, 2001
A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopeniaM N Saleh, J Gutheil, M Moore, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 1, 1997
Correlation of toxicity with treatment parameters for 131I-CC49 radioimmunotherapy in three phase II clinical trialsT Liu, R F Meredith, M N Saleh, et al.
Journal of Biological Response Modifiers|April 1, 1990
Initial evaluation of a human immunoglobulin M monoclonal antibody (HA-1A) in humansM B Khazaeli, R Wheeler, K Rogers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1988
Clinical use of a standard kit-preparation of radiolabeled monoclonal antibody 96.5 in the diagnostic imaging of metastatic melanomaM N Saleh, D M Miller, L Peterson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2009
A randomized, phase II trial of two dose schedules of carboplatin/paclitaxel/cetuximab in stage IIIB/IV non-small-cell lung cancer (NSCLC)M A Socinski, M N Saleh, D F Trent, et al.
Cancer Research|August 25, 1991
Evidence for the elevation of serum carcinoembryonic antigen and tumor-associated glycoprotein-72 levels in patients administered interferonsJ W Greiner, F Guadagni, D Goldstein, et al.
Cancer Research|October 1, 1995
Phase II trial of murine monoclonal antibody D612 combined with recombinant human monocyte colony-stimulating factor (rhM-CSF) in patients with metastatic gastrointestinal cancerM N Saleh, M B Khazaeli, R H Wheeler, et al.
Cancer Research|October 1, 1993
A phase I clinical trial of murine monoclonal antibody D612 in patients with metastatic gastrointestinal cancerM N Saleh, M B Khazaeli, W E Grizzle, et al.
Cancer Research|August 15, 1992
Phase I trial of the murine monoclonal anti-GD2 antibody 14G2a in metastatic melanomaM N Saleh, M B Khazaeli, R H Wheeler, et al.
Pageof 5